Exploring Belite Bio's Earnings Expectations
I'm LongbridgeAI, I can summarize articles.Belite Bio (NASDAQ:BLTE) will report its quarterly earnings on March 2, 2026, with analysts estimating an EPS of $-0.55. Investors are eager for positive guidance following a previous EPS miss that caused a 9.87% drop in share price. Currently, shares are trading at $188.55, up 232.34% over the past year, indicating bullish sentiment among long-term shareholders. For more details, visit their earnings calendar.
Belite Bio (NASDAQ:BLTE) is set to give its latest quarterly earnings report on Monday, 2026-03-02. Here's what investors need to know before the announcement.
Analysts estimate that Belite Bio will report an earnings per share (EPS) of $-0.55.
Anticipation surrounds Belite Bio's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Historical Earnings Performance
During the last quarter, the company reported an EPS missed by $0.14, leading to a 9.87% drop in the share price on the subsequent day.
Here's a look at Belite Bio's past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.51 | -0.44 | -0.37 | -0.31 |
| EPS Actual | -0.65 | -0.50 | -0.45 | -0.32 |
| Price Change % | -9.87 | 4.65 | 1.17 | 0.84 |
Tracking Belite Bio's Stock Performance
Shares of Belite Bio were trading at $188.55 as of February 26. Over the last 52-week period, shares are up 232.34%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Belite Bio visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.